Improving Smoking Cessation Interventions among People Living with HIV (R01 Clinical Trial Optional)
Due date: January 8, 2019, by 5:00 PM
Improving Smoking Cessation Interventions among People Living with HIV (R21 Clinical Trial Optional)
Due date: January 8, 2019, by 5:00 PM
NIDA has just published a RFI seeking wide input from the investigator community towards its HIV/AIDS strategic plan. The notice can be found here: NOT-DA-19-015: Request for Information (RFI): Inviting Comments on the NIDA Strategic plan for Research at the Intersection of HIV/AIDS and Substance Use, Misuse and Addiction.
The deadline for submitting the responses is January 25, 2019. The responses must be submitted electronically through:NIDAHIVStrategicPlan@nida.nih.gov.
The PEER program is an international grants program that is made possible by a Cooperative Agreement between USAID and The National Academies of Sciences, Engineering, and Medicine. It is a 10-year program with a $100 million ceiling and was designed to support collaboration between foreign scientists and United States Government researchers. PEER-eligible countries may be found in the accompanying slides, along with examples of PEER projects with NIH partners.
The PEER Model invites local, in-country scientists to propose a research project that aligns with U. S. congressional priorities and country interests. Additional DC-based core funds are available to support projects deemed meritorious but are not necessarily aligned with the outlined research goals.
The 2018/2019 (Cycle 8) announcement will likely be the last call for projects. The solicitation and goals for Cycle 8 will be announced in the Fall on the PEER website. Pre-proposals will be due to the National Academies around mid-January and selected applicants will be invited to submit a full proposal, which will be due in the beginning of April. More information on the application process may be found here.
Those with questions regarding the program are encouraged to visit the program’s FAQ page.
More info: General PEER Slides 2018
We are delighted to announce that registration has opened for the 4th Inter-CFAR Sub-Saharan Africa Working Group (CFAR-SSA) Symposium, which will take place on February 1-2, 2019 in Machakos, Kenya, at the Maanzoni Lodge, about 30 minutes away from Nairobi airport.
The symposium will include two days of presentations in the scientific focus areas of PrEP, Immunology and Virology, Oral Health, and HIV in Adolescents, as well as a poster reception. In addition, the afternoon before the symposium (1/31) we will hold a half-day career development workshop for junior investigators.
January 31 – February 2, 2019
Deadline: January 7, 2019
The AFP for Prevention Symposium will be held on January 28-29, 2019. The location of the symposium will be at the Emory Conference Center in Atlanta, GA.
Stay tuned for more details about the symposium.
Here are the following grants:
Read more about it here!
The 2019 Miami Winter Symposium will be held on January 27-30. Abstracts are invited for spotlight talks and posters within the following sections:
Abstracts must be submitted by November 30th, 2018.
Here are the following grants:
Read more about it here!
The San Diego Center for AIDS Resarch (SD CFAR) Genomics and Sequencing Core are pleased to present Erik Wendlandt, PhD, for a seminar onTuesday, February 26th, 2019 at 12-1:00pm at UCSD’s CNCB Large Conference Room. Dr. Wendlandt is a field application specialist who will be speaking on “Optimized target detection in qPCR and ddPCR: Better sensitivity through new probe and primer chemistries.” Please note that lunch will be provided in the lobby following the presentation but no food will be allowed inside the conference room.
We are delighted to announce a call for applications for the Sustained Training in Aging and HIV Research (STAHR) Program. This program aims to develop promising scientists into high quality independently-funded researchers whose long-term careers will make a lasting contribution to the area of HIV and aging mental health research, including neurocognitive impairment. The STAHR program is aimed at clinical and translational post-doctoral fellows and junior faculty from across the United States, with previous training in either aging or HIV research, but interested in gaining expertise in the intersection of these two factors. STAHR scholars will attend a 4-week summer institute in 2019 and an annual 2-day workshop over the following three years, which will be held at the University of California San Diego. There will also be a number of remote training opportunities available to scholars during the three years of the program.
Application deadline: March 1st, 2019
Please see the STAHR webpage for further information about the program: https://medschool.ucsd.edu/som/psychiatry/research/stahr/Pages/default.aspx
or contact David Yassai-Gonzalez (Program Coordinator) at email@example.com.
The 3rd La Jolla Aging Meeting (L-JAM), Friday March 29, 2019 will be held at the Salk Institute.
As in previous years, the day will feature talks on biology of aging from students, post docs and faculty from UCSD, SBP, Scripps and Salk. Posters are welcomed and there will be prizes for the best posters – $750, $500 and $250 for 1st, 2nd and 3rd, generously donated by Nanostring.
The keynote lecture will be from Matt Kaeberlein, University of Washington. “New insights into mechanisms by which mTOR modulates metabolism, mitochondrial disease, and aging”
Registration is required, https://www.salk.edu/events/science-events/la-jolla-aging-meeting/
The UC San Diego HIV Institute (THI) and SD CFAR are pleased to present Theodoros Kelesidis, MD, PhD, MSc, in seminar on Thursday, April 4, at 12:00 p.m. in room 143 of the Medical Education and Telemedicine Building on the UC San Diego campus in La Jolla. Dr. Kelesidis is a professor in the Department of Medicine, Infectious Diseases at Ronald Reagan UCLA Medical Center. Lunch will be available for registered participants. See flyer for more details.
Viraj Patel, M.D. will be our featured speaker. He will present on the increased use of social and mobile Internet-based communication technologies (SMT) (e.g., social media, apps, mobile phones, smartphones, SMS), has rapidly become accessible throughout the world, including in low-middle income countries and the digital divide between different socio-demographic groups is rapidly closing. Increasingly, sexual and gender minority populations at high risk of HIV and other populations are reachable around the world using ICT; and these platforms present new opportunities for reaching and engaging communities in ways previously not possible, including through completely online interventions. This talk will discuss development of and results from SMT-based PrEP uptake and HIV testing interventions with young Black/Latinx MSM in the Bronx, New York and MSM in India.
When: April 8th, 2019 at 9:00am PST (12:00pm EST)
Join the zoom here to participate in this webinar.
The Emory CFAR (with planning committee leadership and support from across the HIV & Aging Inter-CFAR Working Group) is co-hosting the 2019 HIV and Aging: From Mitochondria to the Metropolis Conference on April 11-12 at the Courtyard by Marriott Atlanta Decatur Downtown/Emory. The conference will open with a Pre-conference Mentoring Workshop on April 10th. This year’s theme is “Special Populations Aging with HIV.”
Please see below for a call for abstracts and mentoring workshop application announcement, as well as links to more information. We encourage all interested early career investigators to apply! Abstract and mentee application submissions are due on November 30th.
The UC San Diego HIV Institute (THI) and SD CFAR are pleased to present Thomas Hope, PhD, in seminar on Monday, April 22, at 4:00 p.m. in Sanford Burnham Prebys Medical Discovery Institute Building 12 Auditorium on the UC San Diego campus in La Jolla. Dr. Hope is a professor of cell and molecular biology at the Feinberg School of Medicine. A meet-and-greet cocktail reception with appetizers will follow from 5:00 - 6:00 p.m. Please RSVP via Eventbrite by Thursday, April 19. See flyer for more details.
The workshop’s purpose is to understand the mechanisms and epidemiology of viral and non-viral etiologies of liver fibrosis and progression to liver cancer. This workshop includes liver disease and cancer investigators with expertise in basic science, epidemiology, early detection, and clinical research within the United States as well as other experts that span the relevant research spectrum.
It will be held on April 22-23, 2019 in Lipsett Auditorium, Building 10, NIH Main Campus.
Online registration deadline is March 29, 2019. Register at https://bit.ly/2IHVA0n.
Date/Time: Thursday, May 9th, 2019; from 9:00am – 10:00am (PST)
Speaker: Subhashini Sellers, MD (clinical instructor and research fellow at University of North Carolina, Chapel Hill)
Title: HIV Infection is Associated with Suppressed Upper Respiratory Mucosal Immune Response
Registration Link: http://bit.ly/NHLBI_May9
The UC San Diego HIV Institute (THI) and San Diego Center for AIDS Research (SD CFAR) are pleased to present Gary Nabel, MD, PhD in seminar on Thursday, May 9, at 4:00 p.m. in Room 107 of the Leichtag Biomedical Research Building in conjunction with Infectious Diseases Rounds on the UC San Diego campus in La Jolla. Dr. Nabel is the Chief Scientific Officer and Senior Vice President at Sanofi Genzyme.
The California HIV/AIDS Research Program (CHRP) seeks to award approximately $2,000,000 on February 1, 2020 to support pilot studies in basic biomedical HIV science. These pilot awards support early-stage laboratory exploration aimed at understanding mechanisms of HIV prevention, treatment, or cure at the cellular or subcellular level. See flyer here or check out the websitefor more details.
Letter of Intent due date: May 15th, 2019 12:00pm Pacific Time
The HIV/TB Inter-CFAR Working Group will be on Friday, May 17th from 10:00 – 11:00 am PST. Zoom conferencing will be available – details to follow. David Dowdy and Colleen Hanrahan from Johns Hopkins CFAR will present findings from their TB case-finding trial in South Africa. The title of the talk is: “Contact tracing versus facility-based screening for active TB case finding in rural South Africa: A behind-the-scenes look at a pragmatic cluster-randomized trial (Kharitode TB)” If you are interested in joining the working group, you should email Greg Bisson (firstname.lastname@example.org), which will also ensure that you receive the Zoom call login info.
The UC San Diego HIV Institute (THI), San Diego Center for AIDS Research (SD CFAR) and Naviaux Lab are pleased to present Bhupesh Prusty, PhD in seminar on Wednesday, May 22, at 4:00 p.m. in Room 223 of the Medical Education & Telemedicine Building in conjunction with Infectious Diseases Rounds on the UC San Diego campus in La Jolla. Dr. Prusty currently works at the Institute for Virology and Immunobiology, University of Wuerzburg. Please RSVP via Eventbrite by Monday, May 20.
The multidisciplinary, open-access journal PLOS ONE is seeking contributions to this collection. The accepted papers will form a PLOS ONE Collection/PLOS Medicine Special Issue, to be published in November 2019. Contributions should be submitted by 07 June 2019. You can find more information here: https://collections.plos.org/s/substance-use.
Dr. Annick Borquez of the UC San Diego Division of Infectious Diseases and Global Public Health is using her 2019 NIDA Avenir Award to study drug use epidemics in the U.S.
The Emory and Harvard Inter-CFAR Antiretrovirals for Prevention Working Group invite you to participate in our upcoming webinar, Monday, June 10, at 12:00 p.m. June’s webinar will feature Dr. Aaron Siegler. Dr. Siegler is an Associate Professor within the Department of Behavioral Sciences and Health Education at Emory University’s Rollins School of Public Health. His research explores the intersection of the biomedical and behavioral realms, with a focus on sexual minority populations and disparities in healthcare.
Dr. Siegler will be presenting on “Mobile Health Technology and Antiretrovirals for Prevention.” The presentation will focus on the direction of mobile health interventions, the best way to assess them and how to turn them into public health interventions.
The objective of this FOA is to encourage research that addresses gaps in our knowledge of the oral health status of people living with HIV (PLWH), with an emphasis on PLWH who also have non-communicable diseases (NCDs). It supports efforts to understand the combined effects of HIV, antiretroviral therapy (ART), and NCDs on oral health, and it encourages identification of approaches for prevention and treatment of oral diseases and assessment of treatment outcomes in PLWH with or without NCDs. These efforts could help to generate evidence for oral health treatment guidelines tailored to the needs of dental patients with HIV.
LOI Due date: June 29th, 2019
See here for more details
On behalf of the Sustained Training in Aging and HIV Research (STAHR) Program Steering Committee, we cordially invite you to attend the UC San Diego STAHR Workshop, which will take place:
Monday, July 22nd, 8:30am - 2:35pm PST
Tuesday, July 23rd, 9:30am - 1:50pm PST
Location: MET (Medical Education and Telemedicine Building) Room 145
NCI is hosting the 17th International Conference on Malignancies in HIV/AIDS on October 21-22, 2019 at the Lister Hill Center Auditorium on the campus of the National Institutes of Health in Bethesda, Maryland. Abstract Deadline is August 21, 2019. Click here for more details.
The UC San Diego HIV Institute and San Diego Center for AIDS Research are pleased to present the 2019 Mitchell Memorial Lecture, featuring Richard Wyatt, PhD, in seminar on Thursday, September 19, at 4pm in the Auditorium (Room 107) of the Leichtag Biomedical Research Building. Dr. Wyatt is Professor of Immunology, Director of Viral Immunology, IAVI Center for Neutralizing Antibodies at Scripps Research. A reception will immediately follow the lecture. Please RSVP here. The Mitchell Memorial Fund was established by the family of Dr. Richard (Rick) Mitchell, a researcher at UC San Diego, who passed away in 2009. Dr. Mitchell’s memory is honored through an ongoing series of scientific lectures.
The SD CFAR has scheduled an Organized Writing League (OWL) for CROI abstracts. The OWL goal is to provide space, time, community and guidance for writing competitive submissions of all types (meeting abstracts, papers, pilot grants, etc.).
The CROI Abstract OWL will be held on Friday, September 20, from 12:00 - 2:00pm in MET 223, and will be focused on preparing abstracts for CROI. Anyone, including graduate students and post–docs, are welcome to bring their data and ideas. The focus of the session will be to prepare a competitive abstract.
Please let us know if we can provide any additional information or help in any way. We hope to see you there!
The NIAID New Innovator Award (DP2), PAR-19-296, was published last week. The purpose is to support post-doctoral investigators of exceptional creativity who propose highly innovative bold new research with the potential to produce a major impact on broad, important problems in biomedical research relevant to the mission of NIAID. Applicants approved for funding would have one year to secure an independent, tenure-track (or equivalent) faculty position at an U.S. extramural institution to activate the award.
The next receipt date is Oct 10, 2019 (once per year); clinical trials are not allowed for this FOA.
The UC San Diego HIV Institute and San Diego Center for AIDS Research are pleased to present Andrew Henderson, PhD, in seminar on Wednesday October 9, at 4:00pm in the Medical Education and Telemedicine Building, Room 141. Dr. Henderson is Associate Professor of Medicine and Microbiology at Boston University School of Medicine. He will be presenting on “Cellular Mechanisms that Regulate HIV Latency.” Please RSVP here. For those of you who cannot join us in person, please join us via Zoom using a PC, Mac, Linux,iOS or Android: https://uchealth.zoom.us/j/4714740590. You may also call in as follows: US: +1 669 900 6833; meeting ID: 471 474 0590.
The UC San Diego HIV Institute (THI) and San Diego Center for AIDS Research (SD CFAR) are pleased to present Roger Bedimo, MD, in seminar on Thursday, October 24, at 3:30pm at the VA San Diego Health Care System, VAMC—Medical Service Room 3004, 3rd floor Center Core. Dr. Bedimo is Section Chief of Infectious Diseases at the VA North Texas Health Care System. For those of you who cannot join us in person, please note we will attempt to broadcast and record Dr. Bedimo’s lecture via Zoom. Internet access in the seminar room can be challenging at times; we will do our best.
The UC San Diego HIV Institute and the San Diego Center for AIDS Research are pleased to present “Doug Day,” a symposium celebrating Dr. Douglas Richman’s contributions to translational medical research. We have an exciting roster of speakers who were mentored by Dr. Richman in years past, and we are looking forward to an afternoon of science and camaraderie. More information to follow.
When: Friday, November 1, 2019 12:00pm – 4:30pm
Where: UC San Diego Atkinson Pavilion Faculty Club
The NIH Common Fund announces FY2020 funding opportunities for the NIH Director’s Pioneer Award, New Innovator Award, Transformative Research Award, and Early Independence Award in the High-Risk, High-Reward Research program. The program provides unique opportunities for exceptionally creative scientists to pursue highly innovative approaches to address major challenges in biomedical or behavioral research.
The purpose of this “Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21 Clinical Trial Optional)” FOA is to stimulate research on interventions to reduce HIV/AIDS-associated stigma and its impact on the prevention and treatment of HIV/AIDS and on the quality of life of People Living with HIV/AIDS (PLWH). Read more here.
Open Date: October 12, 2019
LOI Due Date: October 12, 2019
AIDS Application Due Date: November 12, 2019 by 5pm
It is time to recruit the next group of promising GloCal fellows for our 2020-21 cohort. The fellowship continues to be open to the same groups of applicants as in previous years with a high emphasis on fellows conducting HIV research. There are 20 eligible GloCal sites in lower and middle income countries. We also have an increased focus on recruiting U.S. postdocs this year. Details can be found here.
Deadline: November 8, 2019